Mature latin businessman showing stock market bar graph to businesswoman. Financial advising team discussing trading patterns of year. Rear view of casual businesspeople holding charts studying year trend together.

Dynavax Technologies Corporation [NASDAQ: DVAX] stock went up by 9.43% or 0.48 points up from its previous closing price of $5.09. The stock reached $5.57 during the last trading session. During the course of the last 5 trading session in the week, DVAX share price went up during 2 out of 5 days, that way gaining +11.18% in the period of the last 7 days.

DVAX had two major price movements with the latest trading session as the price jumped to a high of $5.58, at one point touching $5.10. The latest high is set lower that the high price recorded in the period of the last 52 weeks, set at $5.58. The 52-week high currently stands at $13.03 distance from the present share price, noting recovery -43.68% after the recent low of $2.60.

Dynavax Technologies Corporation [NASDAQ:DVAX]: Analyst Rating and Earnings

Its stock price has been found in the range of 2.60 to 13.03. This is compared to its latest closing price of $5.09.

Keep your eyes peeled for the next scheduled financial results to be made public for this company, which are scheduled to be released on Wed 6 Nov (In 3 Days).

Fundamental Analysis of Dynavax Technologies Corporation [DVAX]

Now let’s turn to look at profitability: with a current Operating Margin for Dynavax Technologies Corporation [DVAX] sitting at -1836.14 and its Gross Margin at -210.04.

This company’s Return on Total Capital is -82.82, and its Return on Invested Capital has reached -93.50%. Its Return on Equity is -121.01, and its Return on Assets is -73.96. These metrics suggest that this Dynavax Technologies Corporation does a poor job of managing its assets, and likely won’t be able to provide successful business outcomes for its investors in the near term.

Turning to investigate this organization’s capital structure, Dynavax Technologies Corporation [DVAX] has

generated a Total Debt to Total Equity ratio of 159.95. Similarly, its Total Debt to Total Capital is 61.53, while its Total Debt to Total Assets stands at 47.83. Looking toward the future, this publicly-traded company’s Long-Term Debt to Equity is -16.12, and its Long-Term Debt to Total Capital is 159.95.

What about valuation? This company’s Enterprise Value to EBITDA is -2.75. The Enterprise Value to Sales for this firm is now 17.96, and its Total Debt to Enterprise Value stands at 0.19. Dynavax Technologies Corporation [DVAX] has a Price to Book Ratio of 9.12.

Shifting the focus to workforce efficiency, Dynavax Technologies Corporation [DVAX] earns $32,924 for each employee under its payroll. Similarly, this company’s Receivables Turnover is 3.60 and its Total Asset Turnover is 0.04. This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 4.08 and its Current Ratio is 4.58. This company, considering these metrics, has a healthy ratio between its short-term liquid assets and its short-term liabilities, making it a less risky investment.

Dynavax Technologies Corporation [DVAX] has 65.09M shares outstanding, amounting to a total market cap of $362.54M. Its stock price has been found in the range of 2.60 to 13.03. At its current price, it has moved down by -57.27% from its 52-week high, and it has moved up 114.64% from its 52-week low.

This stock’s Beta value is currently 0.51, which indicates that it is 6.28% more volatile that the wider market. This stock’s Relative Strength Index (RSI) is at 72.32. This RSI suggests that Dynavax Technologies Corporation is currently Overbought.

Conclusion: Is Dynavax Technologies Corporation [DVAX] a Reliable Buy?

Shares of Dynavax Technologies Corporation [DVAX], overall, appear to be a solid investment option, with Wall Street analysts expecting its price to rise considerably in the next 12 months. This company generates high value from the labor resources and other capital it has available, and while it has heavy Long-Term Debt to Equity, the majority of the metrics point to this investment being highly attractive.